LSI USA '23 filling fast. Register Now

KalVista Pharmaceuticals

Small molecule plasma kallikrein inhibitors for the treatment of diabetic macular edema (DME)

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of KalVista Pharmaceuticals plus 5341 other startups.

Start Free 7 Day Trial Now

Learn More About KalVista Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Our Clients